Dow Up 0.07% Nasdaq Up 0.61%

Veracyte, Inc. (VCYT)

-NasdaqGM
6.64 Up 0.03(0.45%) Nov 26, 4:00PM EST
Prev Close:6.61
Open:6.60
Bid:N/A
Ask:16.12 x 500
1y Target Est:13.83
Beta:N/A
Next Earnings Date:N/A
Day's Range:6.60 - 6.73
52wk Range:6.01 - 19.00
Volume:79,307
Avg Vol (3m):97,572
Market Cap:149.44M
P/E (ttm):N/A
EPS (ttm):-1.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for VCYT

Comparison

Symbol% ChgMkt Cap
VCYTUp 0.45%149.44M
LHUp 1.61%8.63B
DGXUp 0.96%9.31B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.53
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.32
Quarterly EPS Est (Dec-14) :-0.32
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Veracyte, Inc. operates as a diagnostics company in the field of molecular cytology to enhance patient outcomes and lower healthcare costs. It provides Afirma Thyroid FNA Analysis, a solution that consists of its Gene Expression Classifier, which ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback